Aseptuva AG
PrivateLast Round
Grant
May 30, 2025
Total Funding Raised
$2.29M
Company Overview
Aseptuva AG operates in Healthcare & Life Sciences and is based in Bern. Its latest recorded funding round was a Grant round in May 2025.
Aseptuva AG is a medical technology company that develops automated Far-UVC disinfection adaptors for catheters to prevent hospital-acquired infections.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aseptuva AG Comparables
Compare Aseptuva AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Finsen Technologies | 82% | |
| 3C GROUPS A/S | 80% | |
| Xenex Disinfection Services Inc. | 76% |
For institutional investors. Book with your work email.
Aseptuva AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 30, 2025 | ||||
| Seed | Nov 3, 2023 | ||||
| Grant | Nov 3, 2023 | ||||
| Pre Seed | Aug 30, 2022 | ||||
| Grant | Jul 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aseptuva AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fortyone AG | Pre Seed, Seed |
| ValueMaker AG | Pre Seed, Seed |
| Innosuisse | Grant |
| Venture Kick | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2022
$520K round with Fortyone AG and ValueMaker AG.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 19, 2026
Aseptuva Ltd launches a $4.58M Series A to fund clinical development of its Far-UVC catheter-disinfection technology, support UK expansion and enter the US market, after raising US$2.2 million in seed financing backed by healthcare executives and family offices.
- receives_financingSep 19, 2026
Aseptuva Ltd raises $2.2M in a Seed round backed by healthcare executives and family offices, then launches a $4.58M Series A to support clinical development, UK expansion and US market entry.
- receives_financingSep 18, 2026
Aseptuva Ltd raises a $2.91M Seed round in 2025 from healthcare entrepreneurs and investors, including Simon Michel, Roger Nitsch, Armin Diethelm, Auxinam, weInvest, Valuemaker, and Fortyone, to advance its technology from early prototyping to preclinical validation in Europe.
- is_developingSep 18, 2026
Aseptuva Ltd is developing targeted Far-UVC disinfection technology to prevent hospital-acquired infections, particularly catheter-associated bloodstream infections, and is in preclinical validation with development support from Philips Innovation Services, Fraunhofer FEP, and Laser Zentrum.
- receives_financingSep 18, 2026
On Sep 18th '26, Aseptuva Ltd opens a $6.06M Series A round in Switzerland to support clinical development, UK expansion, and preparations for entering the US market; existing shareholders commit more than CHF 400,000.
For institutional investors. Book with your work email.
Aseptuva AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aseptuva AG's valuation, stock price, and market status.
Is Aseptuva AG a public or private company?
Aseptuva AG is a private company.
What is the current stock price of Aseptuva AG?
Aseptuva AG is a private company, so its shares have no public market price. Caplight tracks Aseptuva AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aseptuva AG worth (valuation)?
Valuation information for Aseptuva AG is not publicly available.
Can I buy Aseptuva AG stock?
Aseptuva AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aseptuva AG's last funding round?
Aseptuva AG's most recent funding round was Grant on May 30, 2025.
Who are the main investors in Aseptuva AG?
Key investors in Aseptuva AG include Fortyone AG, ValueMaker AG, Innosuisse, Venture Kick.
Will Aseptuva AG IPO soon?
No public IPO plans have been announced for Aseptuva AG.
How can I track Aseptuva AG secondary market activity?
Caplight tracks bids, offers, and trades in Aseptuva AG's shares on secondary markets.